Twist Bioscience jumps 5.1% as bullish analyst commentary fuels momentum

Twist Bioscience (TWST) is up 5.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks most consistent with follow-through from renewed sell-side optimism after a fresh price-target increase and a broader momentum bid in the name. There did not appear to be a single, definitive company-specific news release tied to today’s jump.

Details:

A price-target increase was published on June 15, 2026, with commentary highlighting demand themes tied to AI-driven workflows and related downstream needs for synthetic biology tools.

The stock had already shown outsized upside volatility in recent sessions, which can attract additional short-term buying from momentum-focused traders and systematic strategies.

Publicly visible SEC activity around this window appeared focused on routine insider-trading filings rather than a new operating update, suggesting the move was more sentiment- than disclosure-driven.

Separately, the company has continued to position its antibody-discovery offering as a growth lever via partnerships and licensing activity, which may be reinforcing the longer-term narrative for investors.

Sources:

Investing.com, Benzinga, Zacks, Twist Bioscience Investor Relations

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$TWST Insider Trading Activity

$TWST insiders have traded $TWST stock on the open market 75 times in the past 6 months. Of those trades, 0 have been purchases and 75 have been sales.

Here’s a breakdown of recent trading of $TWST stock by insiders over the last 6 months:

EMILY M. LEPROUST (Chief Executive Officer) has made 0 purchases and 18 sales selling 107,696 shares for an estimated $6,594,897.
PATRICK JOHN FINN (President and COO) has made 0 purchases and 13 sales selling 116,210 shares for an estimated $5,715,932.
PAULA GREEN (SVP of Human Resources) has made 0 purchases and 9 sales selling 46,967 shares for an estimated $2,454,684.
DENNIS CHO (See Remarks) has made 0 purchases and 10 sales selling 26,257 shares for an estimated $1,605,137.
ADAM LAPONIS (Chief Financial Officer) has made 0 purchases and 9 sales selling 30,439 shares for an estimated $1,586,022.
JAN JOHANNESSEN has made 0 purchases and 2 sales selling 14,200 shares for an estimated $778,834.
ROBERT F. WERNER (Chief Accounting Officer) has made 0 purchases and 9 sales selling 12,125 shares for an estimated $608,233.
ROBERT CHESS has made 0 purchases and 2 sales selling 12,184 shares for an estimated $575,402.
MELISSA A. STAROVASNIK has made 0 purchases and 3 sales selling 3,500 shares for an estimated $231,435.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$TWST Hedge Fund Activity

We have seen 149 institutional investors add shares of $TWST stock to their portfolio, and 136 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 1,821,008 shares (+2641.6%) to their portfolio in Q1 2026, for an estimated $86,534,300
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 1,812,146 shares (+43.7%) to their portfolio in Q4 2025, for an estimated $57,481,271
FARALLON CAPITAL MANAGEMENT LLC added 1,420,000 shares (+18562.1%) to their portfolio in Q1 2026, for an estimated $67,478,400
EDGEPOINT INVESTMENT GROUP INC. added 1,295,672 shares (+31.7%) to their portfolio in Q4 2025, for an estimated $41,098,715
CITADEL ADVISORS LLC added 1,188,351 shares (+3707.9%) to their portfolio in Q1 2026, for an estimated $56,470,439
MILLENNIUM MANAGEMENT LLC removed 1,147,142 shares (-76.6%) from their portfolio in Q1 2026, for an estimated $54,512,187
ARK INVESTMENT MANAGEMENT LLC added 832,687 shares (+12.4%) to their portfolio in Q4 2025, for an estimated $26,412,831

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$TWST Price Targets

Multiple analysts have issued price targets for $TWST recently. We have seen 8 analysts offer price targets for $TWST in the last 6 months, with a median target of $67.5.

Here are some recent targets:

Brendan Smith from TD Cowen set a target price of $89.0 on 06/15/2026
Kyle Mikson from Canaccord Genuity set a target price of $90.0 on 06/15/2026
David Westenberg from Piper Sandler set a target price of $85.0 on 06/11/2026
Catherine Ramsey from Baird set a target price of $65.0 on 05/05/2026
Subbu Nambi from Guggenheim set a target price of $60.0 on 05/05/2026
Luke Sergott from Barclays set a target price of $65.0 on 05/05/2026
Puneet Souda from Leerink Partners set a target price of $70.0 on 05/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.